This suggests that a therapeutic trial with the standard dose of desmopressin is important to differentiate partial CDI, partial nephrogenic diabetes insipidus, and primary polydipsia, if measurements of AVP and copeptin are limited. Here, AVP is linked to clostridium difficile infection.